Robert Klamroth - Concepedia

Author

Robert Klamroth

Also Known As

B Kemkes-Matthes, Ilker Kiris, J. Oldenburg, John Lazarchick, Klamroth Robert, Klamroth, Robert, Klamroth,Robert, López Pina, José Antonio, M. Krause, Mahlangu, Johnny

335

Publications

6.3K

Citations

H-Index

Concepts

All Affiliations

Klinikum im Friedrichshain Goethe University Frankfurt Universität Hamburg Medical University of Vienna University Medical Center Hamburg-Eppendorf

About

Robert Klamroth is an author at Klinikum im Friedrichshain specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	913
2	Public Health	6	6	365
3	Health Sciences	3	3	96
4	Natural Sciences	1	1	14
5	Allergy	1	1	53

Robert Klamroth

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B Steven W. Pipe, Frank W.G. Leebeek, Michael Recht, New England Journal of Medicine	2023	307
Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B Wolfgang Miesbach, Karina Meijer, Michiel Coppens, Blood	2017	295
Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study Andreas Tiede, Robert Klamroth, Rüdiger E. Scharf, Blood	2014	276
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH Johannes Oldenburg, Robert Klamroth, Florian Länger, Hämostaseologie	2021	257
Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial Pratima Chowdary, Stefan Lethagen, Ute Friedrich, Journal of Thrombosis and Haemostasis	2015	215
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A Corien L. Eckhardt, Alice S. van Velzen, Marjolein Peters, Blood	2013	214
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients Elena Santagostino, Claude Négrier, Robert Klamroth, Blood	2012	172
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A Annette von Drygalski, Pratima Chowdary, Roshni Kulkarni, New England Journal of Medicine	2023	160
Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial Pier Mannuccio Mannucci, Christine L. Kempton, Carolyn M. Millar, Blood	2013	128
Deficiencies of antithrombin, protein C and protein S – Practical experience in genetic analysis of a large patient cohort Michael Caspers, Anna Pavlova, Julia Driesen, Thrombosis and Haemostasis	2012	122

Page 1